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Tetraspanin 1 (TSPAN1) has been reported to be upregulated in gastric cancer (GC). However, whilst
TSPAN1 is positively correlated with clinical stage and negatively correlated with survival rates, its
function in GC remains elusive. Here we show that expression of TSPAN1 is signiﬁcantly higher in GC
tissues compared to non-cancerous tissues. Furthermore, we demonstrate that RNAi-mediated
down-regulation of TSPAN1 expression markedly blocks GC cell proliferation, cell cycle progression
and invasive activity. We identiﬁed TSPAN1 as a novel target gene of miR-573. Overexpression of
miR-573 suppressed proliferation and invasion of GC cells by down-regulation of TSPAN1 expres-
sion. Restoration of TSPAN1 rescued the effects of miR-573 overexpression. Therefore, our ﬁndings
suggest that the miR-573/TSPAN1 axis is important in the control of gastric carcinogenesis.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction cancer progression in many human cancers, such as skin squamousGastric cancer (GC) is one of the most common cancers and the
second most common cause of death from cancer worldwide [1].
Despite advancements made in therapeutic strategies, the overall
survival rate for advanced GC is still quite low. The recurrence
and metastasis of GC are very common. Thus, the molecular mech-
anisms which regulate the development and progression of GC
remain to be further elucidated to help to generate more effective
therapies.
Tetraspanins are glycoproteins that consist of four transmem-
brane domains and have 33 members in human [2]. Previous stud-
ies showed that tetraspanins are involved in various fundamental
biochemical processes, such as cell adhesion, cell migration and
intracellular signal transduction [3,4]. As a member of tetraspanin
family, Tetraspanin 1 (TSPAN1) has been reported to regulatecarcinoma, colon cancer, non-small cell lung cancer, and cervical
cancer [5–8]. A previous study has shown overexpressed TSPAN1
in GC clinically [9], indicating that TSPAN1 may be related in
genesis and progression of GC. However, the function of TSPAN1
in GC and molecular mechanism which regulates the development
and progression of GC remains largely unknown.
MicroRNAs (miRNAs) are evolutionarily conserved,
double-stranded and endogenous 22 nucleotides (nt) non-coding
RNAs that regulate the expression of target mRNAs
post-transcriptionally through binding to their 30 untranslated
region (UTR) in sequence-speciﬁcmanner and results in their degra-
dation or silence [10,11]. Previous studies have demonstrated that
miRNAs are involved in various biological processes, such as
proliferation, differentiation, apoptosis, cell cycle, invasion and
metabolism [12]. In addition, the importance of miRNAs in the
pathogenesis and progress of human cancers has also been uncov-
ered [13]. miR-573 has been reported to be associated with RNA
editing, melanoma progression and breast cancer angiogenesis
[14–16]. Wang and colleagues reported that miR-573 was
down-regulated in melanoma tissues and its overexpression
suppressed the proliferation of melanoma cells in vitro and in vivo
by inhibiting the expression of melanoma cell adhesion molecule
(MCAM) [15]. Danza and coworkers found that miR-573 controlled
BRCA 1/2-related breast cancer angiogenesis though targeting key
molecules in focal adhesion, vascular endothelial growth factor
(VEGF) and hypoxia inducible factor-1 (HIF-1) signaling pathways
[16]. Notably, online bioinformatic tools indicate that miR-573 has
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comprehensive picture of the roles of miR-573/TSPAN1 in
human GC.
2. Materials and methods
2.1. Tissue collection
GC tissues and corresponding adjacent non-tumorous gastric
samples were obtained from 20 patients who received operations
at Changhai Hospital (Shanghai, China). All tissues are
snap-frozen in liquid nitrogen immediately and stored at 80 C
until total RNA was extracted. The study was approved by the
ethics committee of Second Military Medical University
(Shanghai, China) and prior patients’ written informed consents
were obtained from all patients.
2.2. Cell lines and cell culture
Human GC cell lines SGC-7901, SUN-1, AGS, HGC-27, BGC-823
and one normal gastric epithelial cell line GES-1 were purchased
from the Institute of Biochemistry and Cell Biology of the
Chinese Academy of Sciences (Shanghai, China). All cell lines were
cultured in RPMI 1640 medium (Invitrogen, Carlsbad, CA) at 37 C
in a humidiﬁed air atmosphere containing 5% CO2.
2.3. RNA extraction and real-time PCR
Total mRNA was isolated using a Rneasy Mini kit (Qiagen,
Hilden, Germany) according to the manufacturer’s instructions.
Complementary DNA was synthesized from 500 ng total RNA,
using the PrimeScript RT Reagent Kit (TaKaRa, Dalian, China).
Real-time PCR was carried out with SYBR Green PCR Master Mix
reagents in the 7900 HT realtime PCR System (Applied
Biosystems, Carlsbad, California, USA) following standard quantita-
tive PCR protocol. The relative expression level of TSPAN1 or
miR-573 was normalized to that of internal control b-actin or U6
by using 2DDCT method. The following primers were used:
miR-573 forward: 50-CTGAAGTGATGTGTAACT-30; miR-573
reverse: 50-GTGCAGGGTCCGAGGT-30; TSPAN1 forward: 50-CGTTG
TGGTCTTTGCTCTTG-30; TSPAN1 reverse: 50-TTCTTGATGGCAGG-
CACTAC-30.
2.4. Vector construction and oligonucleotide transfection
The full length sequence of TSPAN1 30UTR was ampliﬁed from
human genomic DNA and the sequence with mutation in the
miR-573 target site was synthesized. These sequences were cloned
into the ﬁreﬂy luciferase-expressing vector psiCHECK-2 (Promega,
Madison, WI). Primers were: TSPAN1–30UTR-up: 50- ATAGCGATC
GCCTGGCTGCCATGATTGTGT-30; TSPAN1–30UTR-dn: 30-CATGCGGC
CGCTTGGCAACATTGTAACAGG-50; to overexpress TSPAN1, the
fragment of TSPAN1 with or without 30UTR was inserted into
pcDNA3.1. All constructs were veriﬁed by sequencing. The siRNA
sequence for TSPAN1 (50-AGUGCCUGCCAUCAAGAAATT-30),
miR-573 mimics and negative control were purchased from
RiBoBio (Guangzhou, China). Transfection of oligonucleotide into
target cells was carried out using Lipofectamine 2000 reagent
(Invitrogen) according to the manufacturer’s protocol. Cells were
collected 48 h after transfection.
2.5. Production of recombinant adenoviruses
The miR-573 adenovirus and the control EGFP adenovirus were
constructed with the Ad-easy system as described previously [17].Target cells were plated into a 6-well plate in 2 ml of complete
medium at a density of 2  105 cells per well and incubated in
incubator until 80% conﬂuent. The miR-573 adenovirus and the
EGFP adenovirus infected into cells at an MOI = 50. The infection
efﬁciency was assessed by observation of EGFP expression under
ﬂuorescent microscope 48 h after infection.
2.6. Cell proliferation and cell cycle assays
Total of 5000 cells were seeded into 96-well plates and cultured
overnight. Cell proliferation at 24, 48, 72, 96 h after transfection
was determined using Cell Counting Kit-8 (Dojindo, Kumamoto,
Japan) by measuring the absorbance at 490 nm. For cell cycle anal-
ysis, transfected cells were harvested and ﬁxed in 80% ice-cold
ethanol in PBS, then pelleted using a chilled centrifuge and resus-
pended in PBS. The Cells were added with 2 lg/mL of Bovine pan-
creatic RNase (Sigma–Aldrich) and incubated at 37 C for 30 min.
20 lg/mL propidium iodide (PI, Sigma–Aldrich) was then used to
incubated cells for 20 min at room temperature. Cells were subse-
quently analyzed by ﬂow cytometry.
2.7. Transwell invasion assay
Transwell chamber with 8 lm pores (Corning, Cambridge, MA)
and Matrigel (BD Biosciences, San Jose, CA) were used according to
the manufacturer’s instructions. Total of 3  104 cells in 200 ll
serum-free medium were added in triplicate to the upper chamber
pre-coated with Matrigel gel. 500 ll medium containing 10% FBS
were added to the lower chamber as a chemo-attractant.
After 48 h of incubation, the plate inserts were scraped and washed
with PBS several times. Invasive cells were ﬁxed and stained
with 0.1% crystal violet. For each insert, 5 random ﬁelds were
examined under a light microscope, photographed, and counted
manually.
2.8. Luciferase reporter assay
Luciferase reporter assay was performed as described previ-
ously [18]. Brieﬂy, HEK293T cells were transiently transfected with
the luciferase reporter vector containing WT or MUT 30UTR of
TSPAN1 and miR-573 mimics or negative control using
Lipofectamine 2000. After 48 h, cells were harvested and analyzed
for Fireﬂy and Renilla luciferase activities using the Dual-Luciferase
Reporter Assay System (Promega). Activities were normalized to
Renilla luciferase.
2.9. Western blotting
Western blot analysis was carried out as described previously
[19]. Brieﬂy, cells were lysed in RIPA buffer (sigma) along with
Protease Inhibitor (sigma). Proteins were electrophoresed by 10%
SDS–PAGE and then transferred to PVDF membranes (Millipore).
Membranes were blocked with 5% non-fat dried milk and incu-
bated with anti-TSPAN1 (Abcam, Cambridge, MA) or anti-GAPDH
(Cell Signaling Technology, Danvers, MA) antibody overnight. The
corresponding horseradish peroxidase (HRP)-conjugated
immunoglobulin G was incubated at room temperature for 1 h.
Finally, signals were detected by enhanced chemiluminescence
(Pierce).
2.10. Tumor xenograft model
Total of 1.5  106 cell suspensions of BGC-823 cells infected
with miR-573 or control adenovirus were injected subcutaneously
into the right ﬂanks of 6-week-old female BALB/C nude mice. The
body weight and tumor volumes were measured every 5 days
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ume was calculated by using the equation V (mm3) = A  B2/2,
where A, B is the largest diameter and the perpendicular diameter
respectively. The primary tumors were excised and used to the fol-
lowing qRT-PCR and Immunohistochemistry analysis. Tumors
were collected and photographed 30 days after inoculation. All
experiments involving animals were undertaken in accordance
with the National Institute of Health Guide for the Care and Use
of Laboratory Animals, with the approval of the Scientiﬁc
Investigation Board of Second Military Medical University
(Shanghai, China).
2.11. Immunohistochemistry
Parafﬁn sections, 5 lm in thickness, were baked for 2 h at 60 C.
After deparafﬁnization and rehydration, antigen retrieval was per-
formed in sodium citrate buffer. After quenching of endogenous
peroxidase activity with 3% H2O2 in methanol, the sections were
blocked with 10% bovine serum albumin in PBS for 60 min and
incubated with primary antibodies against Ki67 (Abcam). The
immune complex was visualized by Envision + peroxidase system
and DAB-chromogen were applied according to the manufacturer’s
procedures. The nuclei were counterstained with hematoxylin.
2.12. Statistical analysis
All data were expressed as the mean ± S.D. from at least 3
separate experiments performed in triplicate. The differences
between groups were analyzed using Student’s t-test, when
there were only two groups, or assessed by one-way ANOVA
when there were more than two groups. For comparison of
paired tissues, a paired Student’s t-test was used to determine
the statistical signiﬁcance. All of the statistical analyses were
performed using SPSS 17.0 software, and the statistical signiﬁ-
cance was set at P < 0.05.Fig. 1. TSPAN1 is upregulated in GC tissues and knockdown of TSPAN1 inhibits GC cell pr
of GC tissues and their matched normal tissues. (B) Western blotting analysis of TSPAN
(si-TSPAN1) or negative control (NC). (C) Cell viability was determined by CCK-8 assay. (
cells. *P < 0.05.3. Results
3.1. Knockdown of TSPAN1 inhibits GC cell prolifertion and invasion
It has been reported that overexpression of TSPAN1 in humanGC
tissues was signiﬁcantly correlated with the malignant progression
of GC [9]. To further conﬁrm this ﬁnding, we examined the expres-
sion level of TSPAN1 by real-time PCR in 20 pairs of GC tissues and
matched adjacent non-cancerous gastric tissues. As shown in
Fig. 1A, the expression level of TSPAN1 was signiﬁcantly increased
in GC tissues when compared with that in matched adjacent
non-cancerous gastric tissues. To study if TSPAN1 overexpression
was involved in the increased GC cell proliferation and invasion,
speciﬁc siRNAs targeting TSPAN1 (si-TSPAN1) or negative control
(NC) were transfected into two common human GC cell lines,
BGC-823 and HGC-27. As shown in Fig. 1B, si-TSPAN1 reduced the
expressionof TSPAN1protein. CCK-8assay showed that cell viability
was signiﬁcantly decreasedwhen cellswere treatedwith si-TSPAN1
as compared with negative control (Fig. 1C). Cell cycle assay also
revealed a dramatic increase in the percentage of G1/G0-phase cells
and decrease in S-phase cells in si-TSPAN1 transfected cells as com-
pared with negative control (Fig. 1D). Furthermore, we performed
Transwell invasion assay to analyze the role of TSPAN1 on GC
invasive potential. As shown in Fig. 1E, si-TSPAN1 treatment greatly
suppressed cell invasion in both BGC-823 and HGC-27 cells. Taken
together, these results suggest that upregulation of TSPAN1 is
correlated with gastric carcinogenesis and knockdown of TSPAN1
inhibits GC cell proliferation and invasion.
3.2. miR-573 represses TSPAN1 expression by directly targeting its
30UTR
To investigate themechanism of TSPAN1 up-regulation, we used
two web-based target analysis tools (TargetScan and miRanda) to
identify miRNAs that potentially targets TSPAN1. Although manyoliferation and invasion. (A) TSPAN1 expression was detected by qRT-PCR in 20 pairs
1 protein expression in BGC-823 and HGC-27 cells transfected with TSPAN1 siRNA
D) Cell cycle analysis. (E) Representative images (left) and quantiﬁcation of invasive
Fig. 2. miR-573 represses TSPAN1 expression by directly targeting its 30UTR. (A) The putative miR-573-binding sequence in the 30UTR of TSPAN1. (B) 293T cells were
co-transfected with the wild-type (WT) or mutant (MUT) luciferase reporter plasmids and miR-573 mimics or negative control. 48 h after transfection, luciferase activity was
evaluated. (C and D) qRT-PCR and Western blotting were used to examine TSPAN1 mRNA and protein expression levels, respectively. (E) Expression of miR-573 in GC tissues.
*P < 0.05.
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which was projected by both of the algorithms and played a role
in tumor progression. To test the speciﬁcity of the interaction
between miR-573 and TSPAN1 30UTR, we created wide-type and
mutant TSPAN1–30UTR luciferase reporter constructs, in which
full-lengthwide type ormutant 30UTR of TSPAN1was placed down-
stream of the luciferase reporter gene (Fig. 2A). Luciferase reporter
assays showed that when 293T cells were co-transfected with the
wild-type (WT) luciferase reporter plasmids and miR-573 mimics,
the luciferase activity decreased signiﬁcantly as compared with
negative control. However, when the binding site was mutated,
the difference of luciferase activity between miR-573 mimics and
negative control disappeared (Fig. 2B). Furthermore, we measured
the TSPAN1 levels in miR-573 mimics transfected GC cell lines. As
shown in Fig. 2C and D, qRT–PCR and Western blot results showed
that overexpression of miR-573 signiﬁcantly suppressed TSPAN1
expression in BGC-823 and HGC-27 cells. In addition, miR-573
expression was downregulated in GC tissues compared with adja-
cent normal tissues (Fig. 2E). Taken together, these results demon-
strate that miR-573 represses TSPAN1 expression by directly
targeting its 30UTR.
3.3. miR-573 regulates GC cell proliferation and invasion
To study the biological function of miR-573 in GC cells, we ﬁrst
detect the expression levels of miR-573 in ﬁve GC cell lines
(SGC-7901, SUN-1, AGS, HGC-27 and BGC-823) and normal gastric
epithelial cell line GES-1. As shown in Fig. 3A, miR-573 expression
was signiﬁcantly decreased in GC cell lines compared with GES-1,
especially in HGC-27 and BGC-823. We then overexpressed
miR-573 in these two cell lines by infection with adenovirus
expressing miR-573 or negative control (Fig. 3B). Similarly to the
effects of TSPAN1 knockdown, miR-573 overexpression markedly
decreased GC cell growth, induced G1/G0 arrest and inhibited inva-
sion (Fig. 3C–E). These results suggest that miR-573 inhibits GC cell
proliferation and invasion.3.4. Overexpression of TSPAN1 attenuates miR-573-induced inhibition
of GC cell proliferation and invasion
To conﬁrm whether the proliferation and invasion-inhibitory
roles of miR-573 in GC cells was attributable to decreasing the
expression of TSPAN1, we carried out gain-of-function assays by
overexpressing TSPAN1 (without 30UTR) and TSPAN1-30UTR
(with 30UTR) in BGC-823-miR-573 cells. As shown in Fig. 5A,
TSPAN1 plasmid transfection restored TSPAN1 expression,
which was suppressed by miR-573 in BGC-823 cells.
Functional assays showed that overexpression of TSPAN1
signiﬁcantly promoted cell proliferation and increased S phase
cells (Fig. 4B and C). The inhibitory effect of miR-573 on cell
invasion was also antagonized by restoration of TSPAN1
(Fig. 5D). However, overexpressing TSPAN1-30UTR had no
signiﬁcant impact on these parameters (Fig. 5B–D). These
results provide further support that TSPAN1 is a functional
target of miR-573.
3.5. miR-573 suppesses tumorigenicity in vivo
To explore the biological function of miR-573 in GC
tumorigenesis in vivo, we subcutaneously injected BGC-823 cells
infected with adenoviruses expressing miR-573 or control into
the right ﬂanks of nude mice, and tumor formation was moni-
tored. On day 30 after implantation, the mice were euthanized
and tumors were recovered. As shown in Fig. 5A–C, the tumors
formed by miR-573-overexpressing cells were smaller in both size
and weight than the tumors formed by control cells. IHC analysis
revealed that miR-573-overexpressing tumors showed slower
percentages of Ki67-positive cells compared to the control tumors
(Fig. 5D). In addition, qRT-PCR analysis of the tumor tissues con-
ﬁrmed increased miR-573 with decreased TSPAN1 mRNA in
miR-573-overexpressing tumors (Fig. 5E). These results demon-
strate that miR-573 suppresses tumorigenicity of GC cells through
downregulation of TSPAN1.
Fig. 4. Overexpression of TSPAN1 impaires miR-573-induced inhibition of GC cell proliferation and invasion. (A) BGC-823 cells infected by miR-573 adenovirus were
transfected with TSPAN1 vector with or without 30UTR. The expression of TSPAN1 was examined by Western blotting. CCK-8, cell cycle and Transwell assays were
respectively performed to analyze the cell viability (B), cell-cycle distribution (C), and invasive ability (D). *P < 0.05.
Fig. 3. miR-573 suppresses GC cell proliferation and invasion. (A) The expression of miR-573 was examined by qRT-PCR in ﬁve GC cell lines. (B) qRT-PCR of BGC-823 and
HGC-27 cells infected with miR-573 or the corresponding control adenovirus. Effects of ectopic miR-573 expression on the proliferation (C), cell cycle (D), invasion (E) of
BGC-823 and HGC-27 cells were validated by CCK-8, cell cycle and Transwell assays, respectively. *P < 0.05.
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Gastric cancer (GC) is one of the most common human cancers
and always results in an aggressive clinical course. However, the
molecular mechanism under GC tumorigenesis and progression
remains poorly understood. Recently, studies showed thatTSPAN1, one member of the tetraspanin family, overexpressed in
GC clinically [9]. Moreover, TSPAN1 plays crucial roles in regulating
cancer progression in many human cancers [5–8]. In this study, we
explored the function and regulatory mechanism of TSPAN1 in GC.
TSPAN1 is a member of the tetraspanin family, which consists of
four transmembrane domains and has 33 members in human. A
Fig. 5. miR-573 suppresses tumorigenicity of GC cells in vivo. BGC-823 cells infected with adenoviruses expressing miR-573 or control were subcutaneously injected into the
right ﬂanks of nude mice, and tumor formation was monitored. On day 30 after implantation, the mice were euthanized and tumors were recovered. (A) The graph of the
dissected tumors was shown. (B) Tumor volumes were measured on the indicated days. (C) The average tumor weight. (D) Immunohistochemical staining of Ki67 in the
resected tumors. (E) miR-573 and TSPAN1 mRNA expression were assessed by qRT-PCR. *P < 0.05.
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TSPAN1 proteins [9,20–22]. Chen and colleagues showed that
knockdown of TSPAN1 inhibits proliferation, inﬁltration or inva-
sion of human skin squamous carcinoma and colon cancer cells
[5]. Hölters et al. showed that TSPAN1 increases the invasive
potential of cervical cancer cells, whereas proliferation, growth in
soft agar and adhesion are largely unaffected [8]. Notably,
TSPAN1 was also reported to be upregulated in GC tissues [9].
Consistent with this observation, our study conﬁrms that TSPAN1
expression was signiﬁcantly increased in GC tissues when com-
pared matched adjacent non-cancerous gastric tissues. Silencing
TSPAN1 expression by TSPAN1 targeted siRNAs suppressed GC cell
proliferation and invasion, induced cell cycle arrest, and restrained
tumor growth in nude mice. These results suggest that TSPAN1
possesses the characteristics of an oncogenic gene.
miRNAs are usually expressed abnormally in carcinogenesis.
Many miRNAs have been shown to affect the process of GC prolif-
eration, apoptosis and metastasis via repression of speciﬁc target
genes [23,24]. For these reasons, we investigated the possibility
that miRNAs are involved in TSPAN1 upregulation in GC. The
TSPAN1 transcript was predicted to be a direct target of miR-573
by bioinformatics analysis and was conﬁrmed with luciferase
report assay, qRT-PCR and Western blotting. miR-573 has been
shown to be down-regulated in several tumors and correlated with
the growth, angiogenesis, and metastasis potential of cancer
[15,16]. However, the role of miR-573 in GC has not been identi-
ﬁed. In our study, we demonstrated that miR-573 was signiﬁcantly
down-regulated in GC patient specimens. Overexpression of
miR-573 signiﬁcantly reduced proliferation and invasion of GC
cells, mimicking the roles of TSPAN1 silencing. In addition,
re-introduction of TSPAN1 without 30UTR antagonized the func-
tions of miR-573, indicating that TSPAN1 is the primary functional
target of miR-573 in GC.
In summary, our ﬁndings showed that down-regulated miR-573
is responsible for up-regulation of TSPAN1 in GC, and that miR-573
has an important role in GC cell proliferation and invasion by tar-
geting TSPAN1. This newly identiﬁed miR-573/TSPAN1 linkprovides new insight into the mechanisms underlying GC develop-
ment, and may provide novel therapeutic targets for the treatment
of this disease.
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